RecruitingNCT06455293
Psilocybin-assisted therapy for depression in people with Parkinson’s disease
About this title
Read the official source — NCT06455293This study evaluates the effectiveness of Psilocybin for people with depression.
Medication studyAges 40–80United States
Understand this study
What is this study about?
This study evaluates the effectiveness of Psilocybin for people with depression.
Who could participate?
Listed age limits: 40 years to 80 years.
- Listed locations
- San FranciscoSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: August 19, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 60
- Sponsor
- Joshua Woolley, MD, PhD
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 40 Years to 80 Years
- Official registry ID
- NCT06455293
- Official title
Show the full official title
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
San Francisco
Interested in joining this study?
Questions about this study
What is this study about?
This study evaluates the effectiveness of Psilocybin for people with depression.
Who is behind this study?
The study sponsor is Joshua Woolley, MD, PhD.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin and Pimavanserin.
Who can participate?
Listed age limits: 40 years to 80 years.
Is this study still recruiting?
The registry lists this study as recruiting.
